BL Pharmtech Corp. Logo

BL Pharmtech Corp.

Researches, develops, and sells health foods, supplements, and pharmaceuticals.

065170 | KO

Overview

Corporate Details

ISIN(s):
KR7065170003
LEI:
Country:
South Korea
Address:
경기도 용인시 수지구 신수로 767 134호(동천동, 분당수지유타워 지식산업센터), 용인시

Description

BL Pharmtech Corp. is a healthcare company that manufactures, distributes, and sells health functional foods, dietary supplements, and nutraceuticals. The company's portfolio also includes cosmetics, food additives, and pharmaceuticals. A significant part of its operations is dedicated to biotechnology and bio-pharmaceutical research and development. Through its Daedeok Research Institute and in collaboration with subsidiaries BL Melanys and BL Science, the company partners with academic institutions, including KAIST and Columbia University Medical Center, to advance its research initiatives.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-12-16 00:00
주식등의대량보유상황보고서(일반)
Korean 90.8 KB
2024-12-10 00:00
본점소재지변경
Korean 5.1 KB
2024-12-09 00:00
[기재정정]주요사항보고서(감자결정)
Korean 16.6 KB
2024-12-09 00:00
주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소)
Korean 4.6 KB
2024-11-29 00:00
임시주주총회결과
Korean 6.0 KB
2024-11-14 00:00
분기보고서 (2024.09)
Korean 1.1 MB
2024-11-14 00:00
주주총회소집공고
Korean 55.3 KB
2024-10-18 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2024-10-18 00:00
주권매매거래정지 (자본감소)
Korean 4.7 KB
2024-10-18 00:00
주요사항보고서(감자결정)
Korean 13.7 KB
2024-10-18 00:00
주주총회소집결의 (임시주주총회)
Korean 6.0 KB
2024-08-28 00:00
전환가액의조정
Korean 12.0 KB
2024-08-14 00:00
반기보고서 (2024.06)
Korean 1.1 MB
2024-07-26 00:00
[기재정정]타법인주식및출자증권취득결정
Korean 29.1 KB
2024-05-30 00:00
전환가액의조정
Korean 11.6 KB

Automate Your Workflow. Get a real-time feed of all BL Pharmtech Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BL Pharmtech Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BL Pharmtech Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.